JS
Jasjot Singh
Executive
Other
Discover the complete record of transactions filed by Jasjot Singh, Executive. Director active across 1 company, notably Ajooni Biotech Limited. Aggregated, 15 reports have been published. History available since 1 September 2021. The latest transaction was filed on 29 September 2023 (Sale). Regulator: SEBI (PIT + SAST). All data is accessible without signup.
Companies and markets linked to Jasjot Singh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
400,000 shares@ ₹4.529.0% of flowEquity SharesSEBI:dc96494ead1627aca0c6670bb012e09a765f4254
381,803 shares@ ₹4.919.3% of flowEquity SharesSEBI:08b61fdfe43be2570f20a8cdd3884511e5cb390c
210,000 shares@ ₹4.985.1% of flowEquity SharesSEBI:ea4b2363535179dac036f1cd320059b68cad74d4
338,609 shares@ ₹4.828.1% of flowEquity SharesSEBI:12a6d7d16a1e0c62537d05cb6a08df987b1de9be
136,583 shares@ ₹4.753.2% of flowEquity SharesSEBI:0f0f0ae5760943fd64c2806e09eb53eb0dbdfb28
400,000 shares@ ₹5.1510.1% of flowEquity SharesSEBI:0b6aff58b9ec4d9d05fc88984c40e20281ac0759
400,000 shares@ ₹4.689.2% of flowEquity SharesSEBI:0266b8154351f17c7aa1a03cc7e910daca43fc63
171,342 shares@ ₹4.353.6% of flowEquity SharesSEBI:9df48be0ca611f7d23ff6c21fda9897d755ca5e9
400,000 shares@ ₹4.659.1% of flowEquity SharesSEBI:34105740a71c8f268b447e2013dd1859065adc08
189,368 shares@ ₹4.754.4% of flowEquity SharesSEBI:68471b2db9afd67732bfc10905a7ed5755858382
400,000 shares@ ₹4.759.4% of flowEquity SharesSEBI:e2878987a8dbeb0d07ae959d9de92e1e7e893101
43,988 shares@ ₹4.801.0% of flowEquity SharesSEBI:49177072900e3844c4341e3b5147946b1c9eae78
400,000 shares@ ₹4.619.1% of flowEquity SharesSEBI:30fe7fccc3227a1b80abccd2c19b78f308a01890
400,000 shares@ ₹4.659.2% of flowEquity SharesSEBI:26708cb24a08017c8a81a43b853ecfd1c2e54b1e
98,000 shares@ ₹0.00050.0000% mcap100.0% of flowEquity SharesSEBI:0a4cca5cd6b41297abeb90291fbef6a49e96d1c1
About Jasjot Singh
Jasjot Singh is an executive at Ajooni Biotech Limited, a company specializing in the biopharmaceutical sector. He contributes to the management and strategy of the company, which focuses on innovation and the development of health solutions. Ajooni Biotech is committed to improving access to medical treatments through high-quality products.